Experts in Conversation: Baseline Activity Quiz

1 – Which of the following is an advantage of using blood-based biomarkers for the diagnosis of early-stage AD in the near future? (Required)

2 – Which of the following biomarkers tests can be used to select patients for treatment with amyloid-targeting therapies (ATTs­)? (Required)

3 – How confident are you right now in your ability to monitor for amyloid-related imaging abnormalities (ARIA) in your patients receiving ATTs? (Required)